FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2999054805> ?p ?o ?g. }

• W2999054805 endingPage "e83" @default.
• W2999054805 startingPage "e71" @default.
• W2999054805 abstract "Summary Background Systemic sclerosis-associated interstitial lung disease (ILD) carries a high mortality risk; expert guidance is required to aid early recognition and treatment. We aimed to develop the first expert consensus and define an algorithm for the identification and management of the condition through application of well established methods. Methods Evidence-based consensus statements for systemic sclerosis-associated ILD management were established for six domains (ie, risk factors, screening, diagnosis and severity assessment, treatment initiation and options, disease progression, and treatment escalation) using a modified Delphi process based on a systematic literature analysis. A panel of 27 Europe-based pulmonologists, rheumatologists, and internists with expertise in systemic sclerosis-associated ILD participated in three rounds of online surveys, a face-to-face discussion, and a WebEx meeting, followed by two supplemental Delphi rounds, to establish consensus and define a management algorithm. Consensus was considered achieved if at least 80% of panellists indicated agreement or disagreement. Findings Between July 1, 2018, and Aug 27, 2019, consensus agreement was reached for 52 primary statements and six supplemental statements across six domains of management, and an algorithm was defined for clinical practice use. The agreed statements most important for clinical use included: all patients with systemic sclerosis should be screened for systemic sclerosis-associated ILD using high-resolution CT; high-resolution CT is the primary tool for diagnosing ILD in systemic sclerosis; pulmonary function tests support screening and diagnosis; systemic sclerosis-associated ILD severity should be measured with more than one indicator; it is appropriate to treat all severe cases; no pharmacological treatment is an option for some patients; follow-up assessments enable identification of disease progression; progression pace, alongside disease severity, drives decisions to escalate treatment. Interpretation Through a robust modified Delphi process developed by a diverse panel of experts, the first evidence-based consensus statements were established on guidance for the identification and medical management of systemic sclerosis-associated ILD. Funding An unrestricted grant from Boehringer Ingelheim International." @default.
• W2999054805 created "2020-01-23" @default.
• W2999054805 creator A5005002226 @default.
• W2999054805 creator A5005020043 @default.
• W2999054805 creator A5006969715 @default.
• W2999054805 creator A5008396092 @default.
• W2999054805 creator A5008531719 @default.
• W2999054805 creator A5008586570 @default.
• W2999054805 creator A5008642034 @default.
• W2999054805 creator A5009236113 @default.
• W2999054805 creator A5010681869 @default.
• W2999054805 creator A5017405325 @default.
• W2999054805 creator A5018529897 @default.
• W2999054805 creator A5020603336 @default.
• W2999054805 creator A5032641681 @default.
• W2999054805 creator A5034308260 @default.
• W2999054805 creator A5038923266 @default.
• W2999054805 creator A5041780151 @default.
• W2999054805 creator A5047518542 @default.
• W2999054805 creator A5048440937 @default.
• W2999054805 creator A5048636656 @default.
• W2999054805 creator A5049797129 @default.
• W2999054805 creator A5053890524 @default.
• W2999054805 creator A5058325633 @default.
• W2999054805 creator A5059312680 @default.
• W2999054805 creator A5059556786 @default.
• W2999054805 creator A5061710037 @default.
• W2999054805 creator A5061815657 @default.
• W2999054805 creator A5068274512 @default.
• W2999054805 creator A5075326026 @default.
• W2999054805 creator A5078500405 @default.
• W2999054805 creator A5085161164 @default.
• W2999054805 creator A5088005536 @default.
• W2999054805 creator A5089244194 @default.
• W2999054805 date "2020-02-01" @default.
• W2999054805 modified "2023-10-06" @default.
• W2999054805 title "The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements" @default.
• W2999054805 cites W1504572945 @default.
• W2999054805 cites W1582069062 @default.
• W2999054805 cites W1809754406 @default.
• W2999054805 cites W1899271771 @default.
• W2999054805 cites W1969861179 @default.
• W2999054805 cites W2003147099 @default.
• W2999054805 cites W2026641908 @default.
• W2999054805 cites W2042096696 @default.
• W2999054805 cites W2095975942 @default.
• W2999054805 cites W2096766971 @default.
• W2999054805 cites W2098971028 @default.
• W2999054805 cites W2102003406 @default.
• W2999054805 cites W2134785685 @default.
• W2999054805 cites W2165010366 @default.
• W2999054805 cites W2167343941 @default.
• W2999054805 cites W2178931105 @default.
• W2999054805 cites W2206255006 @default.
• W2999054805 cites W2227782510 @default.
• W2999054805 cites W2279787234 @default.
• W2999054805 cites W2291799401 @default.
• W2999054805 cites W2299012047 @default.
• W2999054805 cites W2347093301 @default.
• W2999054805 cites W2347143739 @default.
• W2999054805 cites W2417071353 @default.
• W2999054805 cites W2460459357 @default.
• W2999054805 cites W2498506084 @default.
• W2999054805 cites W2515582198 @default.
• W2999054805 cites W2531669554 @default.
• W2999054805 cites W2549071917 @default.
• W2999054805 cites W2561237922 @default.
• W2999054805 cites W2587952826 @default.
• W2999054805 cites W2592669695 @default.
• W2999054805 cites W2600665403 @default.
• W2999054805 cites W2604976853 @default.
• W2999054805 cites W2605548119 @default.
• W2999054805 cites W2605581274 @default.
• W2999054805 cites W2624827840 @default.
• W2999054805 cites W2742100186 @default.
• W2999054805 cites W2753375198 @default.
• W2999054805 cites W2759213886 @default.
• W2999054805 cites W2765490201 @default.
• W2999054805 cites W2766145635 @default.
• W2999054805 cites W2770035399 @default.
• W2999054805 cites W2772332333 @default.
• W2999054805 cites W2772794207 @default.
• W2999054805 cites W2780425837 @default.
• W2999054805 cites W2782904705 @default.
• W2999054805 cites W2784006802 @default.
• W2999054805 cites W2789284875 @default.
• W2999054805 cites W2794391652 @default.
• W2999054805 cites W2798086449 @default.
• W2999054805 cites W2802836655 @default.
• W2999054805 cites W2803162668 @default.
• W2999054805 cites W2803995891 @default.
• W2999054805 cites W2804710412 @default.
• W2999054805 cites W2807354082 @default.
• W2999054805 cites W2807522798 @default.
• W2999054805 cites W2807695148 @default.
• W2999054805 cites W2809988051 @default.
• W2999054805 cites W2810402656 @default.
• W2999054805 cites W2888353208 @default.

• next